To investigate the ZAP-70 and CD38 expressions and their combined expressions in Sudanese B-CLL patients and their relationships with clinical and hematological characteristics as well as the disease staging at presentation. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.